Is RTN4 p.Pro162Arg (c.485C>G) pathogenic?

RTN4 p.Pro162Arg (c.485C>G) is classified Uncertain significance in RTN4 (ClinVar, Single submitter, 1 submitter; last evaluated 2023-08-29). AlphaMissense: likely benign (0.1375); Rare (popmax 0.114%, mid).

How common is RTN4 p.Pro162Arg (c.485C>G) in the general population?

RTN4 p.Pro162Arg (c.485C>G) is rare (popmax 0.114%, mid) (gnomAD).

What do computational predictors say about RTN4 p.Pro162Arg (c.485C>G)?

AlphaMissense predicts likely benign (score 0.1375) — an in-silico prediction, not a clinical call.

RTN4 p.Pro162Arg

c.485C>G · rs977028125 · VCV2594645

Uncertain significance Single submitter

Classification

Uncertain significance

ClinVar

Review

Single submitter ★☆☆☆

ClinVar · 1 submitter

AlphaMissense

likely benign

0.1375 · ACMG-weighted

gnomAD v4.1

Rare

rare (popmax 0.114%, mid)

Missense predictors

0/3 damaging

AlphaMissense, REVEL, SaProt

Computational evidence

Protein change
AlphaMissense	0.1375	likely benign
REVEL	0.06	moderately benign-leaning
SaProt	LLR -8.41	tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI	—	not assessed · no allele here is in the release
Constraint at this position
Conservation	phyloP 3.8	GERP 0.044, phastCons 0.99
Regional constraint	o/e 1.19	unconstrained · MANE · 77 kb · p 3e-13 · regional, not allelic
Overall
CADD	18.55	PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes

Grpmax group 0.114% Middle Eastern · 4/3,500 alleles

Filtering AF 0.039% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.0235%

Overall 0.00305% 40/1,311,030 alleles · rare exomes 36/1,159,168 · genomes 4/151,862 · joint denominator

Ancestry group	Frequency	1 in
Middle Easterngrpmax	0.114%	875
African / African-American	0.00929%	10,767
Remaining individualsnot grpmax-eligible	0.00404%	24,731
European (non-Finnish)	0.00271%	36,891

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene: RTN4
Protein: p.Pro162Arg
Coding: c.485C>G
MANE Select: NM_020532
dbSNP: rs977028125
Type: single nucleotide variant
Location: chr2:55049816 (GRCh38)
Gene constraint: LOEUF 0.546 · pLI 0.38 (gnomAD)
Structure: AlphaFold pLDDT 40.92 · 2 PDB
Residue 162: the 'disordered' region

Full RTN4 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

RTN4 p.Pro162Thr Uncertain significance ★ ⚠ same residue
RTN4 p.Glu899Gln Benign ★★ same type
RTN4 p.Gly1070Ala Likely benign ★★ same type
RTN4 p.Leu620= Benign ★★ same type
RTN4 p.Leu814Met Likely benign ★★ same type
RTN4 p.Pro992= Benign ★★ same type
RTN4 p.Ser440Asn Benign ★★ same type
RTN4 p.Ser920Cys Benign ★★ same type

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/rtn4-p-pro162arg (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown